Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: A randomized, investigator-blinded study

Current Medical Research and Opinion

Volumn 21, Issue 1, 2005, Pages 61-70

  Riffer, Ernie ^a   Spiller, Joy ^b   Palmer, Robert ^b   Shortridge, Virginia ^b   Busman, Todd A ^b   Valdes, Joaquin ^b  

^a Central Phoenix Medical Clinic   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Acute bacterial sinusitis; Amoxicillin clavulanate; Anti inflammatory; Clarithromycin

Indexed keywords

AMINOTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; CLARITHROMYCIN;

ABDOMINAL PAIN; ACUTE BACTERIAL SINUSITIS; ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; AMINOTRANSFERASE BLOOD LEVEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DYSPNEA; FEMALE; FOLLOW UP; GASTROENTERITIS; HEADACHE; HEALTH CARE UTILIZATION; HUMAN; HYPERTENSION; INCIDENCE; MALE; MULTICENTER STUDY; NAUSEA; NONHUMAN; NOSE SECRETION; PATIENT SATISFACTION; PRESSURE; QUALITY OF LIFE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; SINUSITIS; SYMPTOMATOLOGY; TASTE DISORDER; URTICARIA; VAGINITIS; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; SINUSITIS; TREATMENT OUTCOME;

EID: 14744271687     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904X18009     Document Type: Article

References (27)

1. Brankston ER, Conter HS, Corriveau R, et al. Cefprozil versus cefuroxime axetil in the treatment of acute sinusitis. Clin Drug Invest 1998;15:81-90
2. Gwaltney Jr JM. Acute community-acquired sinusitis. Clin Infect Dis 1996;23:1209-25
3. Ray NF, Baraniuk JN, Thamer M, et al. Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. J Allergy Clin Immunol 1999;103:408-14
4. Scott Levin™ Prescription Audit for Verispan, L.L.C., January-December 2002
5. Physician Drug & Diagnosis Audit (PDDA) from Verispan, L.L.C., January-December 2002
6. Senior BA, Glaze C, Benninger MS. Use of the rhinosinusitis disability index (RSDI) in rhinologic disease. Am J Rhinol 2001;15:15-20
7. Kaliner MA, Osguthorpe JD, Fireman P, et al. Sinusitis: bench to bedside. Current findings, future directions. Otolaryngol Head Neck Surg 1997;116:S1-20
8. Anon JB, Jacobs MR, Poole MD, et al. [Sinus and Allergy Health Partnership]. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130(Suppl 1):1-45
9. Dagan R, Klugman KP, Craig WA, Baquero F. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimicrob Chemother 2001;47:129-40
10. Darkes MJ, Perry CM. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections. Am J Respir Med 2003;2:175-201
11. Fraschini F, Scaglione F, Pintucci G, Maccarinelli G, Dugnani S, Demartini G. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil, and lung in humans. J Antimicrob Chemother 1991;27(Suppl A):61-5
12. Adelglass J, Jones TM, Ruoff G, et al. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. Pharmacotherapy 1998;18:1255-63
13. Clifford K, Huck W, Shan M, Tosiello R, Echols RM, Heyd A, [Sinus Infection Study Group]. Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Ann Otol Rhinol Laryngol 1999;108:360-7
14. Dubois J, Saint-Pierre C, Tremblay C. Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis. Ear Nose Throat J 1993;72:804-10
15. Henry DC, Moller Jr DJ, Adelglass J, et al. [Sparfloxacin Multicenter AMS Study Group]. Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Clin Ther 1999;21:340-52
16. Karma P, Pukander J, Penttila M, et al. The comparative efficacy and safety of clarithromycin and amoxicillin in the treatment of outpatients with acute maxillary sinusitis. J Antimicrob Chemother 1991;27(Suppl A):83-90
17. Lasko B, Lau CY, Saint-Pierre C, Reddington JL, Martel A, Anstey RJ, [The Canadian Sinusitis Study Group]. Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. J Int Med Res 1998;26:281-91
18. Marchi E. Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis. Curr Med Res Opin 1990;12:19-24
19. Fogarty C, et al. Gatifloxacin vs clarithromycin in the management of acute sinusitis. J Resp Dis 1999;20(Suppl):S17-S22
20. Stefansson P, Jacovides A, Jablonicky P, Sedani S, Staley H. Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. Rhinology 1998;36:173-8
21. Murray JJ, Solomon E, McCluskey D, Zhang J, Palmer R, Notario G. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis. Clin Ther 2000;22:1421-32
22. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eighth informational supplement 1998;18:No.1
23. Piccirillo JF. Outcomes research and otolaryngology. Otolaryngol Head Neck Surg 1994;111:764-9
24. Anderson ER, Murphy MP, Weymuller EA. Clinimetric evaluation of the sinonasal outcome test-16. Otolaryngol Head Neck Surg 1999;121:702-7
25. Benninger MS, Appelbaum PC, Denneny JC, Osguthorpe DJ, Stankiewicz JA. Maxillary sinus puncture and culture in the diagnosis of acute rhinosinusitis: the case for pursuing alternative culture methods. Otolaryngol Head Neck Surg 2002;127:7-12
26. Guay DRP, Gustavson LE, Devcich KJ, Zhang J, Cao G, Olson CA. Pharmacokinetics and tolerability of extended-release clarithromycin. Clin Ther 2001;23:566-77
27. Rechtweg JS, Moinuddin R, Houser SM, Mamikoglu B, Corey JP. Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate. Laryngoscope 2004;114:806-10